Skip to main content

Acetaminophen updates

Recently, the FDA approved an IV formulation of acetaminophen (OFIRMEV) for the management of postoperative pain.
The argument for the IV route was to avoid the slow onset of the analgesic effects after oral delivery.

Since the introduction of the injectable formulation, there have been a large number of robust clinical trials on the efficacy of IV acetaminophen (Jones, 2011). Meta-analyses provide a strong indication of the efficacy of the IV formulation in single-dose, randomized, controlled clinical trials, for acute postoperative pain in adults or children.

In one series, 37% of patients receiving i.v. acetaminophen experienced at least 50% pain relief over 4 h compared with 16% (68/527) receiving placebo, with larger effects when baseline pain was greater; fewer patients receiving acetaminophen required rescue medications than those receiving placebo (McNicol et al., 2011). Other analyses demonstrate a significant reduction in postoperative morphine consumption in patients receiving IV acetaminophen (Maund et al., 2011). The analgesic effects of IV acetaminophen display a plateau at doses well above those recommended in the US (e.g., 5 mg/kg; Hahn et al., 2003).

 The recommended dose of OFIRMEV in adults is 1000 mg every 6 hrs, delivered as a 15 min infusion.
The maximum dose is 4000 mg in 24 hrs.
Contraindications are the same as those of oral acetaminophen formulations and include conditions of hepatic impairment or active hepatic disease, alcoholism, chronic malnutrition, severe hypovolemia, or severe renal impairment.

 MECHANISMS OF ACTION

 In fact acetaminophen displayed only modest anti-inflammatory effects.
Some  studies have demonstrated measurable but marginal inhibitory effects of acetaminophen on the COX1, 2, and 3 isoforms (Ouelle and Percival, 2001; Graham and Scott, 2005) suggesting that acetaminophen might act on central pain processing initiated by peripheral tissue injury and inflammation.

 Acetaminophen is deacetylated to p-aminophenol in the liver.
In the brain and spinal chord, p-aminophenol can be conjugated with arachidonic acid by fatty acid amide hydrolase (FAAH) to form N-arachidonoylphenolamine (AM404; Högestätt et al., 2005).
This particular product is an agonist at both TRPV1 (vanilloid or capsaicin) and CB1 (cannabinoid receptors), both of which are expressed heavily in neurons of the spinal and supraspinal pain pathways. While agonists of TRPV1 are thought to activate small primary afferent and produce pain, CB1 agonists are known to reduce nociceptive processing. Indeed, the effects of acetaminophen were reduced by CB1 antagonists (Ottani, et al., 2006).

 We conclude that the mechanism of action of acetaminophen has yet to be fully elucidated
Labels:

Comments

Post a Comment

Popular posts from this blog

power injectable peripherally inserted central catheters

Clinical experience with power injectable peripherally inserted central catheters in intensive care patients     Introduction In intensive care units (ICU), peripherally inserted central catheters (PICC) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome by the use of power-injectable catheters . Method We have retrospectively reviewed all the power injectable PICCs inserted in adult and pediatric patients in the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance. Results We have collected 89 power injectable PICCs (in adults and in children), both multiple and single lumen. All insertions were successful. There were no major complications at insertion and no episodes of catheter-related blood stream infection. Non-infective complications ...
1 comment
Read more

Things to Avoid in Anesthesia for Pregnant with Pulmonary hypertension

Anesthesia for Pregnant woman with Pulmonary Hypertension is a real challenge for anesthesiologist. It is very crucial to remember the pathophysiology of pulmonary hypertension in pregnant women and to avoid some practices that will worsen the cardiac status. 1-Avoid single shot spinal anesthesia. Some authorities consider pulmonary hypertension as absolute contraindication for single shot spinal anesthesia specially in patients with NYHA III ,IV. Spinal anesthesia causes major hemodynamic instability(decrease SVR, decrease VR, decrease in CO) The preferred neuroaxial techniques are (epidural anesthesia and CSE with minimal spinal dose) 2-Avoid PAC. Pulmonary Artery catheters insertion may lead to pulmonary artery rupture or thrombosis. TEE is better cardiac monitor/Arteial line is mandatory. 3-Avoid Nitrous oxide in gas mixture.N2O increase the PVR 4-If MV to be started, avoid High TV and PEEP 5-Avoid Oxytocin Boluses, or rapid administration of Pitocin. Oxytocin causes ...
Post a Comment
Read more

Lumbar and thoracic epidural in Pediatrics-Technical aspect

The midline approach is most commonly used. The ligamentum   flavum is considerably thinner and less dense in infants than in older children and adults. This makes recognition of engagement in the ligament more difficult and requires both extra care and slower, more deliberate passage of the needle to avoid subarachnoid puncture. The angle of approach to the epidural space is slightly more perpendicular to the plane of the back than in older children and adults, owing to the orientation of the spinous   processes in infants and small children. The loss of resistance technique should be used, but only with saline, not air. There are several reports of venous air embolism in infants and children when air was used to test for loss of resistance Use a short (5 cm) 18-gauge Tuohy needle and a 20- or 21-gauge catheter in infants and children. Epidural kits specifically for infants and children are available Maximum of 0.4 mg/kg/hr of bupivacaine after the initial block is estab...
Post a Comment
Read more